You are here: Industry Insights > cancer

News List

ASTRO: NSAIDs May Offer Benefit to Head & Neck Cancer Patients drugs
September 24, 2019
Nonsteroidal anti-inflammatory drugs (NSAIDs) are correlated with better overall survival in patients with head and neck squamous cell carcinoma (HNSCC) ...
Higher Mortality Seen for Male Breast Cancer Patients drugs
September 24, 2019
Male breast cancer patients have higher mortality after cancer diagnosis than female patients, according to a study published online Sept. 19 in JAMA Oncology.
Can Aspirin Help Tackle Some Cancers? drugs
September 24, 2019
Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest.
Colorectal Cancer Mortality Disparities Vary Across U.S. Cities drugs
September 23, 2019
There is considerable variability in colorectal cancer (CRC) mortality disparities across urban cities...
New cancer drugs approvals underpinned by flawed evidence europeanpharmaceuticalreview
September 20, 2019
A new report has shown that trial evidence alone is not enough when approving new cancer drugs and that an assessment of that evidence is also needed.
ASTRO Issues Guideline for Radiation Tx in Pancreatic Cancer drugs
September 20, 2019
In a new American Society for Radiation Oncology clinical practice guideline, published in the September-October issue of Practical Radiation Oncology, recommendations are presented for radiation treatment of pancreatic cancer.
Hysterectomy Procedure Tied to Worse Cancer Outcomes drugs
September 20, 2019
Women who must have their uterus removed should be wary of a procedure called uncontained uterine power morcellation, Yale University researchers warn ...
Men Less Knowledgeable About HPV, HPV Vaccination drugs
September 18, 2019
Men are less knowledgeable than women about human papillomavirus (HPV), HPV vaccination, and the correlation between HPV and cancer, according to a research letter published online in JAMA Pediatrics.
Doubt Over Long-Term Use of Hormone Rx for Recurrent Prostate Cancer drugs
September 18, 2019
Running contrary to current guidelines, new research suggests that use of hormone-suppressing treatment over the long term may not help some men battling recurrent prostate cancer, and may even cause harm.
Gene-targeted cancer drugs, slow release overcome resistance worldpharmanews
September 17, 2019
Biomedical engineers at Duke University have developed a method to address failures in a promising anti-cancer drug, bringing together tools from genome engineering, protein engineering and ...